Celina Ang

2.8k total citations
51 papers, 956 citations indexed

About

Celina Ang is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Celina Ang has authored 51 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 21 papers in Hepatology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Celina Ang's work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Cancer Genomics and Diagnostics (7 papers). Celina Ang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Cancer Genomics and Diagnostics (7 papers). Celina Ang collaborates with scholars based in United States, Italy and United Kingdom. Celina Ang's co-authors include Randall F. Holcombe, Umut Özbek, Sherri Z. Millis, Ghassan K. Abou‐Alfa, Erin Moshier, Myron Schwartz, Eileen M. O’Reilly, Nicole Zubizarreta, Jeffrey S. Ross and Michael Buckstein and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Celina Ang

49 papers receiving 939 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Celina Ang United States 16 338 330 232 224 219 51 956
Daniel Motola‐Kuba Mexico 17 481 1.4× 179 0.5× 218 0.9× 257 1.1× 319 1.5× 49 1.3k
Seiichi Hayato Japan 13 259 0.8× 376 1.1× 125 0.5× 128 0.6× 212 1.0× 26 855
Angelica Petrillo Italy 19 551 1.6× 138 0.4× 233 1.0× 165 0.7× 350 1.6× 68 1.1k
Martina Valgiusti Italy 17 430 1.3× 232 0.7× 202 0.9× 252 1.1× 217 1.0× 55 896
Donglin Sun China 19 266 0.8× 179 0.5× 283 1.2× 117 0.5× 250 1.1× 54 1.0k
Tsai‐Sheng Yang Taiwan 12 315 0.9× 308 0.9× 194 0.8× 151 0.7× 148 0.7× 37 733
Biagio Agostara Italy 16 895 2.6× 255 0.8× 224 1.0× 203 0.9× 343 1.6× 53 1.3k
Lechi Ye China 18 628 1.9× 354 1.1× 589 2.5× 511 2.3× 396 1.8× 48 1.4k
Ken Shimada Japan 22 694 2.1× 113 0.3× 260 1.1× 147 0.7× 437 2.0× 104 1.3k
Alejandra Romero Spain 13 529 1.6× 213 0.6× 182 0.8× 175 0.8× 767 3.5× 20 1.6k

Countries citing papers authored by Celina Ang

Since Specialization
Citations

This map shows the geographic impact of Celina Ang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celina Ang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celina Ang more than expected).

Fields of papers citing papers by Celina Ang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celina Ang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celina Ang. The network helps show where Celina Ang may publish in the future.

Co-authorship network of co-authors of Celina Ang

This figure shows the co-authorship network connecting the top 25 collaborators of Celina Ang. A scholar is included among the top collaborators of Celina Ang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celina Ang. Celina Ang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fulgenzi, Claudia Angela Maria, Antonio D’Alessio, Hong Jae Chon, et al.. (2023). Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic biomarkers in unresectable hepatocellular carcinoma (HCC) treated with atezolizumab plus bevacizumab (atezo-bev).. Journal of Clinical Oncology. 41(4_suppl). 504–504. 1 indexed citations
2.
Adamopoulos, Christos, Tamer A. Ahmed, Maxwell R. Tucker, et al.. (2021). Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling. Cancer Discovery. 11(7). 1716–1735. 40 indexed citations
3.
Marqueen, Kathryn E., Erin Moshier, Michael Buckstein, & Celina Ang. (2021). Neoadjuvant therapy for gastrointestinal stromal tumors: A propensity score‐weighted analysis. International Journal of Cancer. 149(1). 177–185. 11 indexed citations
4.
Dharmapuri, Sirish, Umut Özbek, Jung‐Yi Lin, et al.. (2020). Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti–PD‐1 therapy. Cancer Medicine. 9(14). 4962–4970. 82 indexed citations
5.
Ang, Celina, Sabrina A. Suckiel, Emily R. Soper, et al.. (2020). Lynch Syndrome–Associated Variants and Cancer Rates in an Ancestrally Diverse Biobank. JCO Precision Oncology. 4(4). 1429–1444. 13 indexed citations
6.
Moshier, Erin, et al.. (2019). Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study. Cancer Chemotherapy and Pharmacology. 84(3). 591–598. 92 indexed citations
7.
Dharmapuri, Sirish, et al.. (2019). Outcomes of hepatocellular carcinoma (HCC) patients treated with nivolumab: The Mount Sinai Hospital experience. Annals of Oncology. 30. v294–v294. 3 indexed citations
8.
9.
De, Brian, Ryan Rhome, Vikram Jairam, et al.. (2018). Gastric adenocarcinoma in young adult patients: patterns of care and survival in the United States. Gastric Cancer. 21(6). 889–899. 49 indexed citations
10.
Labgaa, Ismaïl, Carlos Villacorta-Martín, Delia D’Avola, et al.. (2018). A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma. Oncogene. 37(27). 3740–3752. 89 indexed citations
11.
Ang, Celina, Aryeh Stollman, Hongfa Zhu, et al.. (2017). Clinical Benefit from Trametinib in a Patient with Appendiceal Adenocarcinoma with a GNAS R201H Mutation. Case Reports in Oncology. 10(2). 548–552. 12 indexed citations
12.
Kolb, Jennifer M., Umut Özbek, Noam Harpaz, Randall F. Holcombe, & Celina Ang. (2017). Effect of Helicobacter pylori infection on outcomes in resected gastric and gastroesophageal junction cancer. Journal of Gastrointestinal Oncology. 8(3). 583–588. 9 indexed citations
13.
Ang, Celina, et al.. (2016). A Review of Coronary Artery Disease Research in Malaysia.. PubMed. 71(Suppl 1). 42–57. 34 indexed citations
14.
Ang, Celina. (2016). Bisphosphonates as potential adjuvants for patients with cancers of the digestive system. World Journal of Gastroenterology. 22(3). 906–906. 10 indexed citations
15.
Axelrad, Jordan E., Anuja Kriplani, Umut Özbek, et al.. (2016). Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease. Clinical Colorectal Cancer. 16(3). e205–e210. 14 indexed citations
16.
Gian, Richard Kinh, Aoife McErlean, Celina Ang, Ronald P. DeMatteo, & Ghassan K. Abou‐Alfa. (2014). CT and MRI of primary and metastatic fibrolamellar carcinoma: a case series of 37 patients. British Journal of Radiology. 87(1040). 20140024–20140024. 18 indexed citations
17.
Ang, Celina, Eileen M. O’Reilly, & Ghassan K. Abou‐Alfa. (2012). Targeted Agents and Systemic Therapy in Hepatocellular Carcinoma. Recent results in cancer research. 190. 225–246. 19 indexed citations
18.
Griksaitis, Michael & Celina Ang. (2011). Acute altitude induced hypoxia in a child with Down’s syndrome following postoperative repair of complete atrioventricular septal defect. BMJ Case Reports. 2011. bcr0220113866–bcr0220113866. 2 indexed citations
19.
Nadarajan, Veera Sekaran, et al.. (2011). Modification to reporting of qualitative fluorescent spot test results improves detection of glucose‐6‐phosphate dehydrogenase (G6PD)‐deficient heterozygote female newborns. International Journal of Laboratory Hematology. 33(5). 463–470. 12 indexed citations
20.
Lim, Wan‐Teck, Swan Swan Leong, Chee‐Keong Toh, et al.. (2009). A phase I pharmacokinetic study of a liposomal formulation of paclitaxel administered weekly to Asian patients with solid malignancies. Journal of Clinical Oncology. 27(15_suppl). 2581–2581. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Motola‐Kuba Breakdown of academic impact, for papers by Seiichi Hayato Breakdown of academic impact, for papers by Angelica Petrillo Breakdown of academic impact, for papers by Martina Valgiusti Breakdown of academic impact, for papers by Donglin Sun Breakdown of academic impact, for papers by Tsai‐Sheng Yang Breakdown of academic impact, for papers by Biagio Agostara Breakdown of academic impact, for papers by Lechi Ye Breakdown of academic impact, for papers by Ken Shimada Breakdown of academic impact, for papers by Alejandra Romero
Rankless by CCL
2026